We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Italian Medicines Agency Approves NerPharMa to Manufacture CTI’s Drug Pixantrone in European Union
News

Italian Medicines Agency Approves NerPharMa to Manufacture CTI’s Drug Pixantrone in European Union

Italian Medicines Agency Approves NerPharMa to Manufacture CTI’s Drug Pixantrone in European Union
News

Italian Medicines Agency Approves NerPharMa to Manufacture CTI’s Drug Pixantrone in European Union

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Italian Medicines Agency Approves NerPharMa to Manufacture CTI’s Drug Pixantrone in European Union"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cell Therapeutics, Inc. (CTI) has announced that the Italian Medicines Agency (AIFA), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS for the production of CTI's drug candidate pixantrone.

CTI is in the process of preparing a Marketing Authorization Application (MAA) in the European Union for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

"We are pleased that the AIFA has approved the NerPharMa facility to manufacture pixantrone as we continue to receive positive feedback on the clinical trial results from leading clinicians in Europe and make progress in the submission of the MAA in Europe," said Craig W. Philips, President of CTI.
Advertisement